NCT00835887 (ESRD) is a Phase 2 clinical trial of low and high dose flavanoids in End Stage Renal Disease, sponsored by RWTH Aachen University.

Who is sponsoring NCT00835887?

NCT00835887 is sponsored by RWTH Aachen University.

What drugs are being tested in NCT00835887?

Interventions in NCT00835887: low and high dose flavanoids.

What condition does NCT00835887 study?

NCT00835887 studies End Stage Renal Disease.

Is NCT00835887 still recruiting?

NCT00835887 is currently withdrawn. Last updated 23 September 2015.

Last reviewed 2015-09-23 · How we verify

NCT00835887: ESRD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relevance of Flavanols for Cardiovascular Function in End-Stage Renal Disease

Withdrawn Phase 2 Last updated 23 September 2015

What this trial tests

Phase 2 trial testing low and high dose flavanoids in End Stage Renal Disease. Withdrawn.

Quick facts

Lead sponsor	RWTH Aachen University
Phase	Phase 2
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Sites	1 location across Germany

Drugs / interventions tested

low and high dose flavanoids

Conditions studied

End Stage Renal Disease — all drugs for End Stage Renal Disease →

Sponsor

RWTH Aachen University

Who can join

18 and older, any sex, with End Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the acute and long-term effects of flavanols on vascular function in patients with ESRD will be investigated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for End Stage Renal Disease

Currently open trials in the same condition.

NCT06257134 — Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients. · NA · recruiting
NCT06310161 — Light Therapy in End Stage Kidney Disease · NA · recruiting
NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
NCT06422871 — PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis · recruiting
NCT06861816 — Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs · NA · recruiting

Other RWTH Aachen University trials

Trials by the same sponsor.

NCT06390384 — Prevention Programme for Improvement of Well-being and Level of Participation in Adolescents With Enhanced Psychiatric B · NA · not yet recruiting
NCT07322796 — Smoking Cessation Before Bronchoscopy or CT-guided Puncture · recruiting
NCT04996914 — Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma · NA · not yet recruiting
NCT07053956 — Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma · NA · completed
NCT07140536 — The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Perfo · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00835887 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RWTH Aachen University
Last refreshed: 23 September 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00835887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing